Literature DB >> 28432158

Risk score for cardiac surgery in active left-sided infective endocarditis.

Carmen Olmos1, Isidre Vilacosta1, Gilbert Habib2,3, Luis Maroto1, Cristina Fernández1, Javier López4, Cristina Sarriá5, Erwan Salaun2,3, Salvatore Di Stefano4, Manuel Carnero1, Sandrine Hubert3, Carlos Ferrera1, Gabriela Tirado1, Afonso Freitas-Ferraz1, Carmen Sáez5, Javier Cobiella1, Juan Bustamante-Munguira5, Cristina Sánchez-Enrique1, Pablo Elpidio García-Granja4, Cecile Lavoute3, Benjamin Obadia3, David Vivas1, Ángela Gutiérrez5, José Alberto San Román4.   

Abstract

OBJECTIVE: To develop and validate a calculator to predict the risk of in-hospital mortality in patients with active infective endocarditis (IE) undergoing cardiac surgery.
METHODS: Thousand two hundred and ninety-nine consecutive patients with IE were prospectively recruited (1996-2014) and retrospectively analysed. Left-sided patients who underwent cardiac surgery (n=671) form our study population and were randomised into development (n=424) and validation (n=247) samples. Variables statistically significant to predict in-mortality were integrated in a multivariable prediction model, the Risk-Endocarditis Score (RISK-E). The predictive performance of the score and four existing surgical scores (European System for Cardiac Operative Risk Evaluation (EuroSCORE) I and II), Prosthesis, Age ≥70, Large Intracardiac Destruction, Staphylococcus, Urgent Surgery, Sex (Female) (PALSUSE), EuroSCORE ≥10) and Society of Thoracic Surgeons's Infective endocarditis score (STS-IE)) were assessed and compared in our cohort. Finally, an external validation of the RISK-E in a separate population was done.
RESULTS: Variables included in the final model were age, prosthetic infection, periannular complications, Staphylococcus aureus or fungi infection, acute renal failure, septic shock, cardiogenic shock and thrombocytopaenia. Area under the receiver operating characteristic curve in the validation sample was 0.82 (95% CI 0.75 to 0.88). The accuracy of the other surgical scores when compared with the RISK-E was inferior (p=0.010). Our score also obtained a good predictive performance, area under the curve 0.76 (95% CI 0.64 to 0.88), in the external validation.
CONCLUSIONS: IE-specific factors (microorganisms, periannular complications and sepsis) beside classical variables in heart surgery (age, haemodynamic condition and renal failure) independently predicted perioperative mortality in IE. The RISK-E had better ability to predict surgical mortality in patients with IE when compared with other surgical scores. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Cardiac surgery; Endocarditis

Mesh:

Year:  2017        PMID: 28432158     DOI: 10.1136/heartjnl-2016-311093

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

1.  Risk prediction in infective endocarditis by modified MELD-XI score.

Authors:  Peng-Cheng He; Xue-Biao Wei; Si-Ni Luo; Xiao-Lan Chen; Zu-Hui Ke; Dan-Qing Yu; Ji-Yan Chen; Yuan-Hui Liu; Ning Tan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-29       Impact factor: 3.267

2.  Infective endocarditis and outcomes of valve surgery: the bug, the valve, the host and the unknown.

Authors:  Sudarshan Balla; Mohamad Alkhouli
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

3.  Should we include microorganisms in scores to predict outcome in candidates for cardiac surgery during the acute phase of endocarditis?

Authors:  Pierre Tattevin; Pierre Fillâtre; Serge Tchamgoué; Mathieu Lesouhaitier; Nicolas Nesseler; Jean-Marc Tadié
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

4.  Bugs at the operating theatre in infective endocarditis: one step forward, still a long way to go.

Authors:  Juan M Pericàs; Eduard Quintana; José M Miró
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

5.  A Case of Mitral Valve Endocarditis Complicated by Multiple Embolic Phenomena: Leaping from Adult Guidelines to Pediatric Critical Care Decisions.

Authors:  Tarif A Choudhury; Jonathan N Flyer; Henry M Ushay; George Ofori-Amanfo
Journal:  J Pediatr Intensive Care       Date:  2018-11-26

6.  Surgical Procedure Time and Mortality in Patients with Infective Endocarditis Caused by Staphylococcus aureus or Streptococcus Species.

Authors:  Gregor Paul; Laurin Ochs; Christopher Hohmann; Stephan Baldus; Guido Michels; Charlotte Meyer-Schwickerath; Gerd Fätkenheuer; Navid Mader; Thorsten Wahlers; Carolyn Weber; Norma Jung
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

7.  Machine Learning-Based Risk Model for Predicting Early Mortality After Surgery for Infective Endocarditis.

Authors:  Li Luo; Sui-Qing Huang; Chuang Liu; Quan Liu; Shuohui Dong; Yuan Yue; Kai-Zheng Liu; Lin Huang; Shun-Jun Wang; Hua-Yang Li; Shaoyi Zheng; Zhong-Kai Wu
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

8.  Infective Endocarditis: Preliminary Results of a Cohort Study in the Southern Italian Population.

Authors:  Nicola Serra; Claudia Colomba; Paola Di Carlo; Gabriele Palermo; Teresa Fasciana; Anna Giammanco; Giuseppina Novo; Teresa Rea; Maria Michela Marino; Vincenzo Argano; Consolato Sergi
Journal:  Cureus       Date:  2020-05-28

9.  Infective endocarditis at a tertiary care hospital in South Korea.

Authors:  Jung Ho Kim; Hi Jae Lee; Nam Su Ku; Seung Hyun Lee; Sak Lee; Jun Yong Choi; Joon-Sup Yeom
Journal:  Heart       Date:  2020-10-08       Impact factor: 5.994

10.  Analysis of Risk Scores to Predict Mortality in Patients Undergoing Cardiac Surgery for Endocarditis.

Authors:  Fernando Pivatto Júnior; Clarissa Carmona de Azevedo Bellagamba; Eduardo Gatti Pianca; Fernando Schmidt Fernandes; Maurício Butzke; Stefano Boemler Busato; Miguel Gus
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.